La Litiasi Renale Infetta Esperienze in Vitro Ed Uso Clinico Di Un Nuovo Idrossamato Nella Terapia Medica Preventiva

Griffith D. P. , Musher D. M. : Proceedings of the international colloquium on urinary stones. Ed. Finlayson & Thomas: in press.

Griffith D. P. , Musher D. M. , Itin C. : Urease: the primary cause of infection induced urinary stones. Invest. Urol., 13; 346 (1976).

Musher D. M. , Griffith D. P. , Yawn D. , Rosen R. D. : The role of urease in pyelonephritis resulting from urinary infection with Proteus. J. Infect. Dis., 131; 177 (1975).

Wickham J. E. A. : Urinary Calculous Disease, p. 105 (1979).

Musher D. M. , Griffith D. P. , Tyler M. , Woelfel A. : Potentiation of the antibacterial effect of methenamine by acetohydroxamic acid. Antimicr. Agents Chemother., 4; 101 (1974).

Gale G. R. : Urease activity and antibiotic sensitivity of bacteria. J. Bacteriol, 91; 499 (1974).

Summerskill W. H. J. F. , Thorsell J. H. , Aldrete J. S. : Effect of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid. Gastroenterology, 54; 27 (1968).

Wolpert E. A. F. , Hofmann F. , Summerkill W. H. J. : Syntesis and metabolism of labeled acetohydroxamic acid, a urease inhibitor. Proc. Soc. Exp. Biol. Med., 136; 592 (1971).

Martelli A. , Pulini V. , Buli P. : Cristalluria: a valuable parameter in the study of urolithiasis. Advances in nephrourology. Vol. 9, Ed. by Pavone Macaluso M. , & Smith P. H. , p. 251. Plenum Press, New York 1981.

Griffith D. P. , Gibson J. R. , Clinton C. , Musher D. M. : Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. J. Urol., 110; 9 (1978).

Griffith D. P. , Musher D. M. : Prevention of infected urinary stones by urease inhibition. Invest. Urol., 11; 228 (1973).

Musher D. M. , Griffith D. P. , Tiller M. , Woelfel A. : Potentiation of the antibacterial effect of methenamine. Antimicr Agents Chemother., 4; 101 (1974).

Kobashi K. , Kumaki K. , Tamioka S. , Hase J. : Structure activity correlation beetween hydroxamic acids and their inhibitory powers on urease activity. I. Qualitative approach to the effect of hydrophobic character of acyl residue. Chem. Pharm. Bull. Tokio, 20; 8 (1972).

Fishbein W. N. , Daly J. E. : Urease inhibitors for hepatic coma. Comparative efficacy of four lower hydroxamate homologs in vitro and in vivo. Proc. Soc. Exp. Biol. Med., 134; 1083 (1970).

Martelli A. , Buli P. , Brunocilla E. : Acetohydroxamic acid therapy in infected renal stones. Urology, 17; 320 (1981).

Martelli A. , Buli P. , Cortecchia V. : Urease inhibitor therapy in infected stones. Eur. Urol., 7; 291 (1981).

Fishbein W. N. , Streeter C. I. : Physiologic disposition of short chain aliphathic hydroxamates in the mouse. I. The one-through-four carbon hydroxamate; excretion and conversion to amides. J. Pharmacol. Exp. Ther., 174; 239 (1970).